Bemesetron (MDL-72222) is a drug which acts as an antagonist at the 5HT3 receptor.

[1] It has antiemetic effects comparable to metoclopramide,[2] however it is not used clinically, instead its main application is in scientific research studying the involvement of the 5HT3 receptor in the actions of drugs of abuse.

[3][4][5][6] This drug article relating to the gastrointestinal system is a stub.

You can help Wikipedia by expanding it.This drug article relating to the nervous system is a stub.

You can help Wikipedia by expanding it.